Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05682404
Other study ID # OPEDEXA (38RC17.073)
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 1, 2017
Est. completion date June 30, 2018

Study information

Verified date January 2023
Source University Hospital, Grenoble
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Chronic Obstructive Pulmonary Disease (COPD) is a public health problem responsible for high mortality rate and significant costs for society. The disease evolution is punctuated by exacerbations worsening the health state of patients. Many guidelines of care procedures have been written but many disparities persist in medical practices. This pilot prospective observational study is an overview of current local practices in the university health center of Grenoble Alpes and it is the first step towards developing a regional observatory in order to standardize and improve patient cares. The primary outcome is to compare the international guidelines to the local practices regarding the prescription of key treatments of exacerbation, especially antibiotics.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date June 30, 2018
Est. primary completion date March 30, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient older than 18 years (included) - Known or suspected Chronic Obstructive Pulmonary Disease - Admitted for COPD exacerbation in emergency department or pneumology department or intensive care unit of university health center of Grenoble Alpes during the period of data collection. Exclusion Criteria: - opposition to participate at the study - Patients under the law

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France CHU Grenoble Alpes Grenoble

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of antibiotics prescriptions following the guidelines in COPD exacerbation. Adherence to guidelines regarding antibiotics prescription in COPD exacerbation that is justified by :
sputum purulence
severe symptoms
severe comorbidities
pneumonia
up to 30 days
Secondary Percentage of corticosteroids prescriptions following the guidelines in COPD exacerbation. Adherence to guidelines regarding corticosteroids prescription in COPD exacerbation that is :
not a systematic prescription
if needed, it is 30 to 40mg per day of prednisone equivalent and 5 to 7 days maximum
up to 30 days
Secondary Percentage of hospitalization of patients following the guidelines in COPD exacerbation. Adherence to guidelines regarding hospitalization criteria in COPD exacerbation that are :
severe symptoms
respiratory failure
failure of first treatments
severe comorbidities
deficient social environment
patient older than 85 years old
baseline dyspnea around 4 to 5 in Modified Medical Research Council Dyspnea Scale (mMRC scale)
Adherence to guidelines regarding criteria for intensive care unit hospitalization in COPD exacerbation that are :
severe dyspnea not responding to first treatments
neurologic troubles
persistant hypoxemia despite oxygen administration or Non Invasive Ventilation.
respiratory acidosis despite Non Invasive Ventilation
need for invasive mechanical ventilation
hemodynamic instability and need for aminergic support
up to 30 days
Secondary Percentage of non invasive ventilation following the guidelines in COPD exacerbation. Adherence to guidelines regarding criteria for non invasive ventilation in COPD exacerbation that are :
respiratory acidosis
signs of respiratory failure
hypoxemia despite oxygen administration
absence of medical contraindications
up to 30 days
Secondary Percentage of invasive ventilation following the guidelines in COPD Adherence to guidelines regarding criteria for invasive ventilation in COPD exacerbation that are :
failure of non invasive ventilation
medical contraindications for non invasive ventilation
cardiac arrest
neurologic troubles needing sedation
pernicious vomiting
ineffective coughing
up to 30 days
Secondary Percentage of minimal medical examinations following the guidelines in COPD exacerbation. Adherence to guidelines regarding the prescription of minimal medical examinations in COPD exacerbation that is :
complete blood count, kidney function, glucose level
blood gases
chest radiography
electrocardiogram
bacteriological sputum examination only if antibiotic-resistant germ infection is suspected.
up to 30 days
Secondary Percentage of follow-up management after COPD exacerbation following the guidelines Adherence to guidelines regarding follow-up management after COPD exacerbation that is :
adherence to discharge criteria
first medical evaluation one week after discharge
early specialized follow-up into four to six weeks after discharge
up to 30 days
Secondary Frequency of advance directives. Frequency of advance directives written by patients with COPD at day 0
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06000696 - Healthy at Home Pilot
Recruiting NCT03250000 - Changes in Microcirculation and Functional Status During Exacerbation of COPD N/A
Recruiting NCT04142827 - The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) N/A
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT01892566 - Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV N/A
Completed NCT04119856 - Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD N/A
Recruiting NCT06118632 - Physiological and Environmental Data in a Remote Setting to Predict Exacerbation Events in Patients With Chronic Obstructive Pulmonary Disease
Recruiting NCT04860375 - Multidisciplinary Management of Severe COPD N/A
Completed NCT04170361 - The Effect of Incentive Spirometry Added to Routine Physiotherapy Program on Hemodynamic Responses and Hospital Stay in Patients With COPD Exacerbation N/A
Not yet recruiting NCT03696563 - FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS N/A
Not yet recruiting NCT03296215 - Pattern of Admitted Cases in Respiratory Intensive Care Unit at Assiut University Hospitals N/A
Completed NCT03003702 - Domiciliary Monitoring to Predict Exacerbations of COPD N/A
Completed NCT02912689 - NIV - NAVA vs NIV - PS for COPD Exacerbation N/A
Recruiting NCT02264483 - Low-dose CT for Diagnosis of Pneumonia in COPD Exacerbations and Comparison of the Inflammatory Profile. N/A
Completed NCT01443845 - Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) Phase 4
Recruiting NCT02065921 - Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort
Completed NCT04880486 - Weight Training With VR in Out-Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Recruiting NCT03286127 - Palliative Outcome Evaluation Muenster I
Recruiting NCT04638920 - Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy
Not yet recruiting NCT05897125 - Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients N/A